Home›Search›OncoImmunology

OncoImmunology

Landes Bioscience · United States · Est. 1981

ISSN2162-4011

SJR Q1✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

2.542

H-Indexi

151

SNIPi

0.966

Total Worksi

3,897

Total Citationsi

159,115

2yr Mean Citednessi

4.81

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Immunology; Immunology and Allergy; Oncology.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1981

FrequencyBimonthly

StatusActive (last: 2026)

Total Publications3,897

Publisher OrgLandes Bioscience

OA Since2011

Visit Journal Website

Submission Info

Peer Reviewpeer-reviewed

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

Landes Bioscience

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2162-4011

✅

Indexed in a trusted database?

Scopus, PubMed

✅

Peer review process documented?

peer-reviewed

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

207

11k

2019

254

11k

2020

234

7.9k

2021

194

5.6k

2022

129

2.1k

2023

119

1.3k

2024

120

616

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

ImmunologyQ1

Immunology and AllergyQ1

OncologyQ1

Subject Classification

Scopus Categories

ImmunologyImmunology and AllergyOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and InteractionCAR-T cell therapy researchImmune cells in cancerT-cell and B-cell ImmunologyVirus-based gene therapy researchMonoclonal and Polyclonal Antibodies ResearchImmune Response and InflammationPhagocytosis and Immune Regulation

Frequently asked questions about OncoImmunology

Is OncoImmunology a predatory journal?

PubScope has no integrity flags on record for OncoImmunology: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of OncoImmunology?

OncoImmunology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 2.542.

Is OncoImmunology indexed in Scopus and Web of Science?

OncoImmunology is indexed in Scopus.

What is the aims and scope of OncoImmunology?